✦ LIBER ✦

P-586 Phase II study of docetaxel and celecoxib as first or second linetherapy in patients with advanced NSCLC

✍ Scribed by Underhill, C.; Hui, R.; Links, M.; Hawson, G.; Chern, B.; Yip, D.; Blackwell, T.; Crombie, C.; Boyer, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-207 Docetaxel and irinotecan as first

✍ Groth, Gesine; Reck, Martin; Wilke, Hansjochen; Büchele, Thomas; Schäfer, Klaus; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 421 KB

P-560 A randomized phase II study of plv

✍ Raghunadharao, D.; Koralewski, P.; Serwatowski, P.; Gruszfeld, A.; Lakshmaiah, K 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Phase II study of docetaxel (DOC) and ca

✍ van Putten, J.W.G; Slebos, D.J; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

P-559 A phase II study of oxallplatln an

✍ Raez, L.; Santos, E.; Rocha-Lima, C.; Roman, E.; Kumar, P.; Farfan, N.; Decesare 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 143 KB

A phase II study of docetaxel (D) and ge

✍ Agelaki, S.; Papadakis, E.; Tsiafaki, X.; Rapti, A.; Toubis, M.; Bania, E.; Kalb 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 158 KB

P-218 A phase II study of cisplatin and

✍ Ohe, Yuichiro; Niho, Seiji; Watanabe, Koshiro; Yokoyama, Akira; Saijo, Nagahiro; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB